Endocrine, nutritional, and metabolic diseases (E00-E90).
- Obesity (obesity)
- Autoantibodies against insulin
- Diabetes mellitus type 2 (age-related diabetes) – leads to peripheral insulin resistance (reduced effectiveness of endogenous insulin at target organs skeletal muscle, adipose tissue and liver).
- Ectopic insulin secretion – secretion of insulin from a site other than the pancreas (pancreas).
- Congenital hyperinsulinemia (CHI) – usually due to an ion channel mutation of the ATP-sensitive potassium channel; pathologically (pathologically) increased insulin secretion by beta cells.
Neoplasms – tumor diseases (C00-D48).
- Insulinoma – rare, usually benign (benign) tumor of endocrine cells (islets of Langerhans) of the pancreas (pancreas) in which increased insulin is produced.
Genitourinary system (kidneys, urinary tract – sex organs) (N00-N99).
- Chronic renal insufficiency (kidney weakness).
Medication
- Overdose of insulin or insulin secretagogue (repa-/nateglinide).
- Sulfonylureas – oral antidiabetic drug (drug used in type 2 diabetes mellitus).
